Tucson, AZ – October 12, 2026, NuvOx Therapeutics, Inc. (“NuvOx”), a clinical-stage biotechnology company developing NanO2™, a novel oxygen therapeutic designed to enhance oxygen delivery to oxygen-de
TUCSON, AZ, July 15, 2026 — NuvOx Therapeutics, Inc. (“NuvOx Therapeutics”, “NuvOx”, or the “Company”) today announces that its wholly owned subsidiary, NuvOx Pharma LLC, has been granted Fast Track
Tucson, Arizona — April 30, 2026 — NuvOx Therapeutics (“NuvOx”), a clinical-stage biotechnology company developing oxygen therapeutics for life-threatening hypoxemic conditions, today announced positi
Comments